Connect Biopharma Holdings LCNTB
13F holders, Q4 2025 (December 31)At the end of Q4 2025, 28 institutions reported holding Connect Biopharma Holdings L (CNTB) in their 13F filings, up 13 from Q3 2025. 14 opened new positions and 2 sold out. The largest holders were Ikarian Capital, LLC ($13.5M), Boothbay Fund Management, LLC ($3.5M) and Perceptive Advisors LLC ($2.2M). 4 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Connect Biopharma Holdings L
- CUSIP
- G23549101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 14 | $21.4M |
| Exits | 2 | $41K |
All 13F filers, Q3 2025 → Q4 2025: 7,732,543 shares bought and 901,652 shares sold, net +6,830,891 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 28 holders
| Ikarian Capital, LLC | 1.75% | New | 4,788,486 | $13.5M |
| Boothbay Fund Management, LLC | 0.09% | New | 1,234,582 | $3.5M |
| Perceptive Advisors LLC | 0.04% | New | 792,696 | $2.2M |
| BML Capital Management, LLC | 1.02% | Reduce -67.7% | 408,887 | $1.2M |
| Knott David M Jr | 0.26% | New | 200,000 | $564K |
| Richmond Brothers, Inc. | 0.31% | New | 173,485 | $489K |
| Renaissance Technologies | 0.00% | Reduce -9.5% | 143,100 | $404K |
| Marshall Wace, LLP | 0.00% | Add +121.2% | 128,368 | $362K |
| Citadel Advisors | 0.00% | New | 99,493 | $281K |
| Jane Street Group, LLC | 0.00% | New | 82,226 | $232K |
| OMERS ADMINISTRATION Corp | 0.00% | New | 80,808 | $228K |
| Susquehanna International Group, LLP | 0.00% | Add +420.1% | 71,503 | $202K |
| Koa Wealth Management, LLC | 0.10% | No change | 49,600 | $140K |
| Millennium Management | 0.00% | New | 47,050 | $133K |
| Royal Bank of Canada | 0.00% | New | 40,400 | $114K |
| Persistent Asset Partners Ltd | 0.04% | New | 26,774 | $76K |
| Geode Capital Management, LLC | 0.00% | No change | 23,320 | $66K |
| HRT Financial LP | 0.00% | Add +60.5% | 16,785 | $47K |
| Point72 Asset Management | 0.00% | New | 16,503 | $47K |
| SmartHarvest Portfolios, LLC | 0.01% | — | 12,897 | $36K |
| Monograph Wealth Advisors, LLC | 0.00% | No change | 11,130 | $31K |
| Qube Research & Technologies Ltd | 0.00% | New | 10,449 | $29K |
| UBS Group AG | 0.00% | Add +1474.6% | 3,165 | $9K |
| Morgan Stanley | 0.00% | Add +2109.0% | 2,209 | $6K |
| Rhumbline Advisers | 0.00% | No change | 780 | $2K |
| JPMorgan Chase & Co. | 0.00% | No change | 121 | $341 |
| Simplex Trading, LLC | 0.00% | New | 98 | $276 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -14.3% | 6 | $17 |
"% of holder's portfolio" is CNTB's weight in each manager's 13F, not the share of Connect Biopharma Holdings L the manager owns.